Release Date: 31/08/11 14:03 Summary: Half Yearly Report and Accounts Price Sensitive: Yes Download Document 216.5KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%